Abstract
BackgroundEfficacy and safety of intravenous (IV) tocilizumab (TCZ) have been shown in patients (pts) with pcJIA.1ObjectivesDetermine appropriate dosing regimens of SC TCZ in pcJIA.MethodsPts were aged 1–17 y with pcJIA,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
